U1 snRNP regulates cancer cell migration and invasion in vitro

Stimulated cells and cancer cells have widespread shortening of mRNA 3’-untranslated regions (3’UTRs) and switches to shorter mRNA isoforms due to usage of more proximal polyadenylation signals (PASs) in introns and last exons. U1 snRNP (U1), vertebrates’ most abundant non-coding (spliceosomal) small nuclear RNA, silences proximal PASs and its inhibition with antisense morpholino oligonucleotides (U1 AMO) triggers widespread premature transcription termination and mRNA shortening. Here we show that low U1 AMO doses increase cancer cells’ migration and invasion in vitro by up to 500%, whereas U1 over-expression has the opposite effect. In addition to 3’UTR length, numerous transcriptome changes that could contribute to this phenotype are observed, including alternative splicing, and mRNA expression levels of proto-oncogenes and tumor suppressors. These findings reveal an unexpected role for U1 homeostasis (available U1 relative to transcription) in oncogenic and activated cell states, and suggest U1 as a potential target for their modulation. U1 snRNP is a key regulator of mRNA biogenesis through its roles in splicing, and transcription and 3’-end processing. Here the authors show a tumor suppressor-like function of U1 snRNP using in vitro cell migration/invasion assays and transcriptome profiling.

[1]  C. Croce,et al.  Non‐coding RNAs in cancer initiation and progression and as novel biomarkers , 2011, Molecular oncology.

[2]  B. Tian,et al.  Reprogramming of 3′ Untranslated Regions of mRNAs by Alternative Polyadenylation in Generation of Pluripotent Stem Cells from Different Cell Types , 2009, PloS one.

[3]  R. Elkon,et al.  The Poly(A)-Binding Protein Nuclear 1 Suppresses Alternative Cleavage and Polyadenylation Sites , 2012, Cell.

[4]  Zhenghe Wang,et al.  microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. , 2009, Cancer research.

[5]  C. Mayr,et al.  Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.

[6]  S. Sugano,et al.  Frequent pathway mutations of splicing machinery in myelodysplasia , 2011, Nature.

[7]  Philip Bradley,et al.  U2AF1 mutations alter splice site recognition in hematological malignancies , 2014, bioRxiv.

[8]  F. Westermann,et al.  1p36 tumor suppression--a matter of dosage? , 2012, Cancer research.

[9]  Jianzhong Su,et al.  3′ UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk , 2018, Nature Genetics.

[10]  Y. Shiloh,et al.  Genotype-phenotype relationships in ataxia-telangiectasia and variants. , 1998, American journal of human genetics.

[11]  Ping Zhu,et al.  Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types. , 2018, Cell reports.

[12]  M. Zavolan,et al.  Means to an end: mechanisms of alternative polyadenylation of messenger RNA precursors , 2013, Wiley interdisciplinary reviews. RNA.

[13]  David Tuck,et al.  A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. , 2011, The Lancet. Oncology.

[14]  S. Roman-Roman,et al.  Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage , 2016, Nature Communications.

[15]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[16]  D. Rio,et al.  JUM is a computational method for comprehensive annotation-free analysis of alternative pre-mRNA splicing patterns , 2018, Proceedings of the National Academy of Sciences.

[17]  Larry N. Singh,et al.  U1 snRNP Determines mRNA Length and Regulates Isoform Expression , 2012, Cell.

[18]  A. Gregory Matera,et al.  A day in the life of the spliceosome , 2014, Nature Reviews Molecular Cell Biology.

[19]  R. DuBois,et al.  Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.

[20]  J. Manley,et al.  The Polyadenylation Factor CstF-64 Regulates Alternative Processing of IgM Heavy Chain Pre-mRNA during B Cell Differentiation , 1996, Cell.

[21]  Wei Li,et al.  CFIm25 links Alternative Polyadenylation to Glioblastoma Tumor Suppression , 2014, Nature.

[22]  G. Dreyfuss,et al.  A Complex of U1 snRNP with Cleavage and Polyadenylation Factors Controls Telescripting, Regulating mRNA Transcription in Human Cells. , 2019, Molecular cell.

[23]  George A. Calin,et al.  MicroRNAs — the micro steering wheel of tumour metastases , 2009, Nature Reviews Cancer.

[24]  Christine Unger,et al.  In vitro cell migration and invasion assays. , 2013, Mutation research.

[25]  Qian Wang,et al.  GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data , 2012, Bioinform..

[26]  Larry N. Singh,et al.  U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation , 2010, Nature.

[27]  Margaret S. Ebert,et al.  Roles for MicroRNAs in Conferring Robustness to Biological Processes , 2012, Cell.

[28]  K. Inokuchi,et al.  Alternative poly(A) site-selection regulates the production of alternatively spliced vesl-1/homer1 isoforms that encode postsynaptic scaffolding proteins , 2007, Neuroscience Research.

[29]  Mihaela Zavolan,et al.  Genome-wide analysis of pre-mRNA 3' end processing reveals a decisive role of human cleavage factor I in the regulation of 3' UTR length. , 2012, Cell reports.

[30]  N. Matter,et al.  Targeted ‘knockdown’ of spliceosome function in mammalian cells , 2005, Nucleic acids research.

[31]  Steven W. Flavell,et al.  Genome-Wide Analysis of MEF2 Transcriptional Program Reveals Synaptic Target Genes and Neuronal Activity-Dependent Polyadenylation Site Selection , 2008, Neuron.

[32]  B. Williams,et al.  Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.

[33]  J. Bonner,et al.  Differentiation , 1968, Nature.

[34]  Christina S. Leslie,et al.  Widespread intronic polyadenylation inactivates tumor suppressor genes in leukemia , 2018, Nature.

[35]  P. Sharp,et al.  Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites , 2008, Science.

[36]  J. Yates,et al.  An Mtr4/ZFC3H1 complex facilitates turnover of unstable nuclear RNAs to prevent their cytoplasmic transport and global translational repression , 2017, Genes & development.

[37]  N. LaRusso,et al.  MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. , 2008, The Journal of clinical investigation.

[38]  H. Deeg,et al.  SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition. , 2015, Cancer cell.

[39]  J. Goeman,et al.  Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation , 2012, Nucleic acids research.

[40]  L. Steinmetz,et al.  Polyadenylation site–induced decay of upstream transcripts enforces promoter directionality , 2013, Nature Structural &Molecular Biology.

[41]  Christopher B. Burge,et al.  Promoter directionality is controlled by U1 snRNP and polyadenylation signals , 2013, Nature.

[42]  Ji Wan,et al.  Transcriptome-wide analyses of CstF64–RNA interactions in global regulation of mRNA alternative polyadenylation , 2012, Proceedings of the National Academy of Sciences.

[43]  Zhi Cheng,et al.  Gene expression profiling reveals U1 snRNA regulates cancer gene expression , 2017, bioRxiv.

[44]  K. Nishida,et al.  Mechanisms and consequences of alternative polyadenylation. , 2011, Molecules and Cells.

[45]  B. L. Caputto,et al.  Growth of Peripheral and Central Nervous System Tumors Is Supported by Cytoplasmic c-Fos in Humans and Mice , 2010, PloS one.

[46]  Christine Mayr,et al.  Widespread intronic polyadenylation diversifies immune cell transcriptomes , 2018, Nature Communications.

[47]  Y. Mandel-Gutfreund,et al.  A complex immunodeficiency is based on U1 snRNP‐mediated poly(A) site suppression , 2012, The EMBO journal.

[48]  F. Slack,et al.  The let-7 microRNA represses cell proliferation pathways in human cells. , 2007, Cancer research.

[49]  Auinash Kalsotra,et al.  Systematic Profiling of Poly(A)+ Transcripts Modulated by Core 3’ End Processing and Splicing Factors Reveals Regulatory Rules of Alternative Cleavage and Polyadenylation , 2015, PLoS genetics.

[50]  Karin Milde-Langosch,et al.  The Fos family of transcription factors and their role in tumourigenesis. , 2005, European journal of cancer.

[51]  L. Cartegni,et al.  Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation. , 2011, Molecular cell.

[52]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[53]  Andrea J. Kriz,et al.  Transcriptional Pause Sites Delineate Stable Nucleosome-Associated Premature Polyadenylation Suppressed by U1 snRNP. , 2018, Molecular cell.

[54]  J. Mendell,et al.  MicroRNAs in Stress Signaling and Human Disease , 2012, Cell.

[55]  Hongmin Li,et al.  A Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers , 2008, PLoS genetics.

[56]  G. Dreyfuss,et al.  U1 snRNP telescripting regulates a size–function-stratified human genome , 2017, Nature Structural & Molecular Biology.